The in vii effcts ofxenoestrogens are ofinterest in relation to their potential health risk and/or beneficial efficts on humans and animals. However, the apparent in yim potency of the examined response can be confounded by a short half-ife, and the metabolism of estogens is very dependent on the nature of conversion and/or inactivation. To minimize such variables, we examined the estrogenic potency of a range of xenoestrogens in an acute in vivo assay-the stimulation of increased uterine vascular permeability in ovariectomized mice 4 hr after subcutaneous administra. tion. While estradiol (E2) and estriol (F3; a relatily weak natural estrogen) readily induced vascular responses [median effiv dose (ED50) 10-9 mol], much higher amounts of xenoestrogens were required. Bisphenol A was about 10,000-fold less potent than E4 and E, and octylphenol and nonylphenol were about 100,000-fold less potent; dioctyl phthalat, beyl buty ptalate, dibutyl phtbalate, and trichlorinated biphenol produced no effect. Coumestrol was the most active phytoestrogen, with an ED50 between 10-6 and 10-7 mol; genistein wa about 10-fold less potent than coumestrol, and neither daidzein nor formononetin produced any marked efflect, even at doses up to 1O5mol. All increases in vascular permeability could be blocked by the pure antiestrogen ICI 182,780. There was no evidence that any ofthe compounds could act as an aniesrogen in his assay or that they could exert ynegistc ef in. combion. These results indicate that even short-term exposure to most of the xenobiotic estogens can induce typical estrogenic efFecs in vivo, but their esuogenic potency is very weak even when assessed in an acute response.
There is considerable public and scientific interest in the potential effects of the exposure of humans and other animals to environmental estrogens. These nonsteroidal estrogenic compounds essentially fall into two categories: they are derived from either dietary sources or industrial sources. The recent surge of interest in this area has largely come from the use of very sensitive in vitro assays, which have allowed the identification of weak estrogenic activity in many industrially derived chemicals (1) . This has been coupled with natural and experimental observations of estrogenic effects in aquatic animals (e.g., fish) living under conditions of continuous exposure to the compounds (2) . The possible health benefits of diets rich in phytoestrogens has provided an additional and alternative focus of attention (3) .
While the existence of dietary and environmental compounds with estrogenic activity is clear, speculation linking them to epidemiological data on fertility, reproductive abnormalities, and disease is severely hampered by our very poor understanding of the in vivo biological activity of these compounds. In vitro assays have established that all the compounds are relatively weak estrogens, with both binding affinity to the estrogen receptor and in vitro biological activity usually <1/1,000 of estradiol (4) . However, it is difficult to extrapolate from such in vitro data to the in vivo situation in which the biological activity is dependent on the complex in vivo pharmacokinetics associated with uptake, distribution, metabolism, and excretion.
There have been virtually no systematic, detailed studies of the nature and time course of the estrogenic effects of these chemicals in vivo in mammals. As a first stage to assessing the in vivo estrogenic activity, this study was undertaken to establish the relative potency of the compounds in an acute in vivo mammalian assay. In vivo, the complex pattern of estrogenic action on the uterus can be dissociated into a group of early responses (e.g., increased vascular permeability, uterine edema, uterine eosinophilia) and a group of later responses (a host of biochemical changes leading to cell division, differentiation, and uterine growth) (5) .
Estimates of estrogenic potency are markedly affected depending on which of these two groups of responses are used as the baseline. Thus while estriol and estradiol are relatively similar when assessed in terms of the ability of single subcutaneous (sc) injections to induce early uterine responses, such single exposures to estriol are considerably less effective than estradiol in producing sustained effects due to the rapid dissociation of estriol from its receptor (5 Log of injected doses (mol) Figure 1 . The dose-response effects of 1713-estradiol, estriol, and the environmental estrogens bisphenol A, octylphenol, and nonylphenol on uterine vascular permeability 4 hr after subcutaneous administration in ovariectomized mice. Saline controls were included for each experimental data point Vascular permeability was determined by the extravascular accumulation of [12511-albumin and was expressed as extravascular albumin volume (EAV; see Methods). The data are expressed as mean ± standard error (n = 6-12). Where no error bars are shown, the errors were smaller than the symbol. Statistical significance was determined by comparison with the controls. *p<0.05; **p".01; lp<0.001.
very effective in stimulating vascular permeability, with a median effective dose (ED50) <10-9 mol. All the other industrial compounds were required at considerably higher doses before any increase in uterine vascular permeability was observed (Fig. 1) , and some showed no effect at all. Compared to E21
bisphenol A was about 10,000 times less effective in inducing the uterine vascular response (ED50 -10-5 mol), and octylphenol and nonylphenol were about 100,000 times less effective (ED50 _104 mol). The three phthalates, dioctyl phthalate, benzyl butyl phthalate, and dibutyl phthalate (104 mol), and trichlorinated biphenol (10-8 mol) produced no significant effect on uterine vascular permeability.
Coumestrol was the most potent of the phytoestrogens (ED50 between 106 and 10-7 mol), but still required 100-1,000-fold higher doses of the compound than E2 (Fig. 2) . (10-4 mol) , and uterine vascular permeability was determined. There was no evidence that any of the environmental estrogens (at the doses given) produced any significant (p<0.05) inhibitory effect on the estradiol-stimulated increase in vascular permeability. The index of vascular permeability was 12.9 ± 2.5 .l/mg (mean ± SE) for E2 (10o mol) alone, while the combination of E2 with the other estrogenic compounds gave values of 10.3 ± 1.5 for nonylphenol and octylphenol (each at a dose of 10-6 mol), 14 ± 2.8 for bisphenol A (10-8 mol), and 11.4 ± 1.6 for dioctyl phthalate, 12.1 ± 1.8 for dibutyl phthalate, and 14.9 ± 1.1 (pd/mg for benzyl butyl phthalate (all at doses of 10-mol).
Experiment 4-The effects ofcombinaions ofa variety ofenvironmentl estrogens on uterine vascularpermeability. The effect of low doses of different compounds given in combination was examined to determine whether there was any evidence of synergistic interactions in the induction of increases in uterine vascular permeability. Ovariectomized mice were injected sc with one of the following combinations: 1) nonylphenol (10-6 mol), octylphenol (10-6 mol), and bisphenol A (10-7 mol); and 2) dibutyl phalate (10-4 mol), dioctyl phalate (10-4 mol), and benzyl butyl phalate (104 mol). There was no evidence of any significant (p>0.05) postive or negative synergy or negative effects between the compounds (at the doses used) in any of the combinations tested in terms of inducing an increase in vascular permeability. In control uteri, the index of vascular permeability was 4.2 ± 0.51 pil/mg (mean ± SE); the combination of nonylphenol with octylphenol (both at 10-6 mol) and bisphenol A (10-7 mol) produced an index of 2.91 ± 0.27 Pl/mg; for dibutyl phthalate with benzyl butyl phthalate and dioctyl phthalate (all at 10-3 mol), the index of vascular permeability was 2.79 ± 0.54 pl/mg. Discussion
The availability of very sensitive in vitro bioassays for estrogens has led to the identification of estrogenic activity in many industrial (11, 12) and plant-derived compounds (13) . However, even in vitro assays, the estrogenic activity of these compounds is usually less than 1/1,000-1/100,000 that of E2 (1, 4, (11) (12) (13) . Our data is in general agreement with published data on the in vitro potency of the xenobiotic estrogens, emphasizing that these compounds can only exert significant estrogenic activity when present in very large quantities. Bisphenol A appears to be one of the more potent xenobiotic estrogens (14, 15) ; a recent in vivo study in rats examining prolactin secretion (14) suggested that bisphenol A was only 100-500-fold less active than E2, while bisphenol A potency in vitro was 1,000-5,000-fold less than E2. In the present study, bisphenol A was about 10,000-fold less potent than E2.
These observations, coupled with the present observations, suggest that in vitro potencies of xenobiotic estrogens may not be an accurate guide to in vivo potencies, and estimates of in vivo potency will depend on the assay used.
The in vivo estrogenic potency ofxenobiotic estrogens has received rather superficial attention, with results largely based on uterine growth after daily sc injections (16) or after administration by gavage (17) . However, the relative potency of estrogenic compounds depends on a number of factors, including the route of administration and the nature of the response monitored. The particular problem of using uterine growth respotnses to assess estrogenic potency is well illustrated by comparing the effects of E2and E3. while single sc injections ofeither of these hormones are very effective in inducing rapid uterine responses (that occur within a few hours of administration), E3 is unable to mimic E2 in terms of the uterine growth response measured at 24 hr after injection (5) . Such differences in estrogenic responses led to E3 being described as a weak estrogen (18) . However, the apparent low potency of single injections of E3 to induce uterine growth hides the biological reality of the estrogenic response. E3 is fully effective in producing the complete ranige of estrogenic responses when it is given as rapidly repeated injections (5) vivo assay that allows the estrogenic activity of the relatively weak E3 to be exposed, the potency of all the weak environmental estrogens was considerably lower. This would tend to emphasize that prolonged in vivo estrogenic responses to such compounds are unlikely to occur unless the exposures are both considerable and extended; this is currently under investigation. However, the possibility that acute exposures to these compounds may induce significant, although short-term, estrogenic responses should not be underemphasized. Rapid responses to estrogens are an important feature of a number of reproductive processes, such as control of the cell cycle (5) and the sensitivity of the uterus to an implanting blastocyst (20) ; exogenous estrogenic agents may be able to either mimic endogenous estrogens and/or provide a disturbance to the sequence of endogenous estrogenic stimulation essential for the normal pattern of uterine responses. 
